| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Italy | 10 | |
| #2 | China | 7 | |
| #3 | WIPO (World Intellectual Property Organization) | 7 | |
| #4 | EPO (European Patent Office) | 6 | |
| #5 | Mexico | 6 | |
| #6 | Canada | 5 | |
| #7 | Australia | 3 | |
| #8 | New Zealand | 2 | |
| #9 | Argentina | 1 | |
| #10 | Brazil | 1 | |
| #11 | Japan | 1 | |
| #12 | Republic of Korea | 1 | |
| #13 | United States | 1 | |
| #14 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Foods and drinks | |
| #5 | Measurement | |
| #6 | Environmental technology | |
| #7 | Civil engineering |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Steroids | |
| #4 | Fermentation | |
| #5 | Organic chemistry methods | |
| #6 | Foods | |
| #7 | Special foods | |
| #8 | Analysing materials | |
| #9 | Climate change adaptation technologies | |
| #10 | Finishing work on buildings |
| # | Name | Total Patents |
|---|---|---|
| #1 | Ajani Mauro | 39 |
| #2 | Moro Luigi | 31 |
| #3 | Villa Roberto | 23 |
| #4 | Pedrani Massimo | 10 |
| #5 | Fossati Lorenzo | 8 |
| #6 | Celasco Giuseppe | 7 |
| #7 | Gianni Luigi | 2 |
| #8 | Gerloni Mara | 2 |
| #9 | Piersante Pasquale | 2 |
| #10 | Roberto Villa | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP2453243A1 | Method for the diagnosis and/or follow up of the evolution of a tumor | |
| NZ599437A | Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives. | |
| WO2007031349A1 | Use of c3-c10 17alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents. | |
| WO2005074718A1 | Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders | |
| ITMI20041295A1 | ORAL ANTI-MICROBIAL PHARMACEUTICAL COMPOSITIONS | |
| EP1516977A1 | Panel, in particular for wood floors | |
| AU5077200A | Mesalazine controlled release oral pharmaceutical compositions |